Showing results (51-60 of 668) with videos related to

Sort By:
Pageof 67
Diabetology International|January 4, 2019
Usefulness of glycated albumin in decisions regarding the discontinuation of a diabetes drug and factors associated with poor glycemic control following discontinuation in patients with type 2 diabetes mellitusNorio Masumoto, Hiroaki Otsuki, Seigo Iwakawa, et al.
Diabetology International|January 4, 2019
Insulin degludec in a simple or stepwise titration algorithm in a Japanese population of patients with type 2 diabetes: a randomized, 26-week, treat-to-target trialTakashi Kadowaki, Hideaki Jinnouchi, Kohei Kaku, et al.
Diabetology International|January 4, 2019
Impact of metabolic syndrome on the incidence of type 2 diabetes in middle-aged Japanese individuals with impaired insulin secretion: the Saku studyAkiko Morimoto, Yukako Tatsumi, Nao Sonoda, et al.
Diabetology International|January 4, 2019
Causes of death in Japanese patients with diabetes based on the results of a survey of 45,708 cases during 2001-2010: report of Committee on Causes of Death in Diabetes MellitusJiro Nakamura, Hideki Kamiya, Masakazu Haneda, et al.
Diabetology International|January 4, 2019
Reliability and validity of revised and short form versions of diabetes diet-related quality of life scaleEiko Sato, Ryota Ochiai, Taiga Shibayama, et al.
Diabetology International|January 4, 2019
High glycated albumin (GA) levels and the GA/HbA1c ratio in patients with insulin autoimmune syndromeMasafumi Koga, Shinya Inada, Jun Taniguchi, et al.
Diabetology International|January 4, 2019
The effects of ipragliflozin on the liver-to-spleen attenuation ratio as assessed by computed tomography and on alanine transaminase levels in Japanese patients with type 2 diabetes mellitusYukihiro Bando, Ayumi Ogawa, Kazuhide Ishikura, et al.
Diabetology International|January 4, 2019
Immune regulation of glucose and lipid metabolismTsuguhito Ota
Diabetology International|January 4, 2019
Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes receiving conventional therapy: clinical implication of the importance of exercise habits during treatment with ipragliflozinMitsutoshi Kato, Kumiko Sakai, Kyoko Saito, et al.
Diabetology International|January 4, 2019
Joint impact of modifiable lifestyle behaviors on glycemic control and insulin resistance in patients with type 2 diabetes: the Fukuoka Diabetes RegistryToshiaki Ohkuma, Masanori Iwase, Hiroki Fujii, et al.
Pageof 67